ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
FDA Approves Odactra for House Dust Mite Allergies
americanpharmaceuticalreview
March 03, 2017The U.S. Food and Drug Administration has approved Odactra, the first allergen extract to be administered under the tongue (sublingually) to treat house dust mite (HDM)-induced nasal inflammation (allergic rhinitis), with or without eye inflammation (conj -
FDA approves Odactra for house dust mite allergies
worldpharmanews
March 02, 2017The U.S. Food and Drug Administration today approved Odactra the first allergen extract to be administered under the tongue (sublingually) to treat house dust mite (HDM)-induced nasal inflammation (allergic rhinitis).
Pharma Sources Insight January 2025
